In vitro anticancer studies of α- and β-d-glucopyranose betulin anomers

Chemico-Biological Interactions

Volumn 185, Issue 2, 2010, Pages 128-136

  Kommera, Harish ^a   Kaluderović, Goran N ^a,b   Bette, Martin ^a   Kalbitz, Jutta ^c   Fuchs, Petra ^c   Fulda, Simone ^d   Mier, Walter ^e   Paschke, Reinhard ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c BioSolutions Halle GmbH   (Germany)

^d Klinik fuanddie r Kinder und Jugendmedizin   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Apoptosis; Betulin; Betulinic acid; Caspase; Cytotoxicity

Indexed keywords

28 O ACETYLBETULIN 3 YL ALPHA DEXTRO (2',3',4',6' TETRA O ACETYL)GLUCOPYRANOSIDE; 28 O ACETYLBETULIN 3 YL ALPHA DEXTRO GLUCOPYRANOSIDE; 28 O ACETYLBETULIN 3 YL BETA DEXTRO (2',3',4',6' TETRA O ACETYL)GLUCOPYRANOSIDE; 28 O ACETYLBETULIN 3 YL BETA DEXTRO GLUCOPYRANOSIDE; BETULIN; CASPASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; GLUCOSE; HCT116 CELLS; HUMANS; ISOMERISM; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; TIME FACTORS; TRITERPENES; X-RAY DIFFRACTION;

EID: 77952104700     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.02.038     Document Type: Article

References (37)

1. Baglin I., Mitaine-Offer A.C., Nour M., Tan K., Cave C., Lacaille-Dubois M.A. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents. Mini Rev. Med. Chem. 2003, 3:525-539.
2. Cichewicz R.H., Kouzi S.A. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med. Res. Rev. 2004, 24:90-114.
3. Eiznhamer D.A., Xu Z.Q. Betulinic acid: a promising anticancer candidate. IDrugs 2004, 7:359-373.
4. Yogeeswari P., Sriram D. Betulinic acid and its derivatives: a review on their biological properties. Curr. Med. Chem. 2005, 12:657-666.
5. Alakurtti S., Makela T., Koskimies S., Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. Eur. J. Pharm. Sci. 2006, 29:1-13.
6. Dzubak P., Hajduch M., Vydra D., Hustova A., Kvasnica M., Biedermann D., Markova L., Sarek J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep. 2006, 23:394-411.
7. Mukherjee R., Kumar V., Srivastava S.K., Agarwal K., Burman A.C. Betulinic acid derivatives as anticancer agents: structure activity relationship. Anticancer Agents Med. Chem. 2006, 6:271-279.
8. Pisha E., Chai H., Lee I.S., Chagwedera T.E., Farnsworth N.R., Cordell A.C., Beecher C.W.W., Fong H.H.S., Kinghorn A.D., Brown D.M., Wani M.C., Wall M.E., Hieken T.J., Das Gupta T.K., Pezzuto J.M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1995, 1:1046-1051.
9. Safayhi H., Sailer E.R. Antiinflammatory actions of pentacyclic triterpenes. Planta Med. 1997, 63:487-493.
10. Honda T., Liby K.T., Su X., Sundararajan C., Honda Y., Suh N., Risingsong R., Williams C.R., Royce D.B., Sporn M.B., Gribble G.W. Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A. Bioorg. Med. Chem. Lett. 2006, 16:6306-6309.
11. Fujioka T., Kashiwada Y., Kilkuskie R.E., Cosentino L.M., Ballas L.M., Jiang J.B., Janzen W.P., Chen I., Lee K.H. Anti-AIDS agents betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 1994, 57:243-247.
12. Huang L., Ho P., Lee K.H., Chen C.H. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. Bioorg. Med. Chem. 2006, 14:2279-2289.
13. Steele J.C., Warhurst D.C., Kirby G.C., Simmonds M.S. In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother. Res. 1999, 13:115-119.
14. Lugemwa F.N., Huang F.Y., Bentley M.D., Mendel M.J., Alford A.R. A Heliothis zea antifeedant from the abundant birchbark triterpene, betulin. J. Agric. Food Chem. 1990, 38:493-496.
15. Huang F.Y., Chung B.Y., Bentley M.D., Alford A.R. Colorado potato beetle antifeedants by simple modification of the birch bark triterpene betulin. J. Agric. Food Chem. 1995, 43:2513-2516.
16. Hayek E.W.H., Moche W., Sauter F. A bicentinial of betulin. Phytochemistry 1989, 28:2229-2242.
17. Fulda S., Jeremias I., Steiner H.H., Pietsch T., Debatin K.M. Betulinic acid: a new cytotoxic agent against malignant brain tumor cells. Int. J. Cancer 1999, 82:435-441.
18. Schmidt M.L., Kuzmanhoff K.L., ing-Indeck L.L., Pezutto J.M. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer 1997, 33:2007-2010.
19. Zuco V., Supino R., Righetti S.C., Clerics K., Marchesi E., Gambacorti-Passerini C., Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines but not normal cells. Cancer Lett. 2002, 175:17-25.
20. Fulda S., Friesen C., Los M., Scaffidi C., Mier W., Benedict M., Nunez G., Krammer P.H., Peter M.E., Debatin K.M. Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 1997, 57:4956-4964.
21. Fulda S., Scaffidi C., Susin S.A., Krammer P.H., Kroemer G., Peter M.E., Debatin K.M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 1998, 273:33942-33948.
22. Fulda S., Debatin K.M. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med. Pediatr. Oncol. 2000, 35:616-618.
23. Mullauer F.B., Kessler J.H., Medema J.P. Betulin is a potent anti-tumor agent that is enhanced by cholesterol. PLoS One 2009, 4:e5361.
24. Flekhter O.B., Medvedeva N.I., Karachurina L.T., Baltina L.A., Zarudii F.S., Galin F.Z., Tolstikov G.A. Synthesis and antiinflammatory activity of new acetylated betulin derivatives. Pharm. Chem. J. 2002, 36:488-491.
25. Tolmacheva I.A., Shelepen¢kina L.N., Vikharev Yu.B., Anikina L.V., Grishko V.V., Tolstikov A.G. Synthesis and biological activity of S-containing betulin derivatives. Chem. Nat. Comp. 2005, 41:701-705.
26. K.M. Debatin, S. Fulda, M. Wiessler, M. Los, W. Mier, Betulinic acid and derivatives thereof useful for the treatment of neurectodermal tumors, WO0024762, 2000.
27. Zhao G., Yan W. Synthesis of betulin-3yl-β-d-glucopyranoside. J. Carbohydr. Chem. 2009, 28:234-243.
28. Sheldrick G.M. The SHELX programs for crystal structure determination. Acta Cryst. A 2008, 64:112-122.
29. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82:1107-1112.
30. Dietrich A., Mueller T., Paschke R., Kalinowski B., Behlendorf T., Reipsch F., Fruehauf A., Schmoll H.J., Kloft C., Voigt W. (2-(4-(Tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diammine) dichloroplatinum(II): a novel platinum compound that overcomes cisplatin resistance and induces apoptosis by mechanisms different from that of cisplatin. J. Med. Chem. 2008, 51:5413-5422.
31. Thongdeeying P., Chantrapromma S., Fun H.K., Anjum S., Ali S., Ponglimanont C. 2-(9-Hydroxy-3a, 5a,5b,8,8,11a-hexamethylicosa-hydro-1H-cyclopenta[a]chrysen-1-yl)propano ic acid (3β-hydroxylupan-29-oic acid). Acta Cryst. 2005, E61:1861-1863.
32. Allen F.H., Kennard O., Watson D.G., Brammer L., Orpen A.G., Taylor R. Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. J. Chem. Soc., Perkin Trans. 2 1987, 12:S1-19.
33. Sarek J., Klinot J., Dzubak P., Klinotova E., Noskova V., Krecek V., Kori{dotless}nkova G., Thomson J.O., Janostakova A., Wang S., Parsons S., Fischer P.M., Zhelev N.Z., Hajduch M. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships. J. Med. Chem. 2003, 46:5402-5415.
34. H. Kommera, G.N. Kaluderović, J. Kalbitz, R. Paschke, Microwave mediated synthesis and structure-activity relationships of betulin and betulinic acid derivatives, synthesis and anticancer activity of novel betulinic acid and betulin derivatives, Arch. Pharm., in press.
35. H. Kommera, G.N. Kaluderović, J. Kalbitz, R. Paschke, Lupane triterpenoids-betulin and betulinic acid derivatives induce apoptosis in tumor cells, Invest. New Drugs, in press, doi:10.1007/s10637-009-9358-x.
36. Rzeski W., Stepulak A., Szymański M., Sifringer M., Kaczor J., Wejksza K., Zdzisińska B., Kandefer-Szerszeń M. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 2006, 374:11-20.
37. Rzeski W., Stepulak A., Szymański M., Juszczak M., Grabarska A., Sifringer M., Kaczor J., Kandefer-Szerszeń M. Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro. Basic Clin. Pharmacol. Toxicol. 2009, 105:425-432.